Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells

Current Pharmaceutical Biotechnology

Volumn 15, Issue 9, 2015, Pages 839-846

  Wang, Xinmei ^a   Huang, Xiaomeng ^a   Yang, Zhaogang ^a   Gallego Perez, Daniel ^a   Ma, Junyu ^a   Zhao, Xi ^a   Xie, Jing ^a   Nakano, Ichiro ^a   James Lee, L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Ohio State University   (United States)

Author keywords

Cancer initiating cells; Cancer stem cells; Glioma stem cells; Targeted delivery; Transferrin conjugated nanoparticles

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA 1; NANOPARTICLE; PROTEIN TYROSINE KINASE; TRANSFERRIN CONJUGATED LIPOPOLYPLEX NANOPARTICLE; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; MET PROTEIN, HUMAN; MICRORNA; MIRN1 MICRORNA, HUMAN; POLYETHYLENEIMINE; SCATTER FACTOR RECEPTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; CANCER GENE THERAPY; CARCINOGENICITY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL VIABILITY ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG STABILITY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY RESISTANCE; TRANSWELL MIGRATION ASSAY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; BRAIN TUMOR; CELL MOTION; CELL SURVIVAL; CHEMISTRY; GENETICS; METABOLISM; PROCEDURES; STEM CELL; TUMOR CELL CULTURE;

BRAIN NEOPLASMS; CELL MOVEMENT; CELL SURVIVAL; GLIOBLASTOMA; HUMANS; MICRORNAS; NANOPARTICLES; POLYETHYLENEIMINE; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TRANSFERRIN; STEM CELLS; TRANSFECTION; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 84924959382     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666141031105234     Document Type: Article

References (43)

1. Hess, K.R.; Broglio, K.R.; Bondy, M.L. Adult glioma incidence trends in the United States, 1977-2000. Cancer, 2004, 101, 2293- 2299.
2. Bao, S.; Wu, Q.; McLendon, R.E.; Hao, Y.; Shi, Q.; Hjelmeland, A.B.; Dewhirst, M.W.; Bigner, D.D.; Rich, J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444, 756-760.
3. Kim, E.; Kim, M.; Woo, D.H.; Shin, Y.; Shin, J.; Chang, N.; Oh, Y.T.; Kim, H.; Rheey, J.; Nakano, I.; Lee, C.; Joo, K.M.; Rich, J.N.; Nam, D.H.; Lee, J. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell, 2013, 23, 839-852.
4. Joshi, K.; Banasavadi-Siddegowda, Y.; Mo, X.; Kim, S.H.; Mao, P.; Kig, C.; Nardini, D.; Sobol, R.W.; Chow, L.M.; Kornblum, H.I.; Waclaw, R.; Beullens, M.; Nakano, I. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Stem Cells, 2013, 31, 1051-1063.
5. Guessous, F.; Zhang, Y.; Kofman, A.; Catania, A.; Li, Y.; Schiff, D.; Purow, B.; Abounader, R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle, 2010, 9, 1031- 1036.
6. Wang, H.; Lathia, J.D.; Wu, Q.; Wang, J.; Li, Z.; Heddleston, J.M.; Eyler, C.E.; Elderbroom, J.; Gallagher, J.; Schuschu, J.; MacSwords, J.; Cao, Y.; McLendon, R.E.; Wang, X. F.; Hjelmeland, A.B.; Rich, J.N. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells, 2009, 27, 2393-2404.
7. Wang, X.; Yu, B.; Ren, W.; Mo, X.; Zhou, C.; He, H.; Jia, H.; Wang, L.; Jacob, S.T.; Lee, R.J.; Ghoshal, K.; Lee, L.J. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J. Control Release, 2013, 172, 690- 698.
8. Nohata, N.; Hanazawa, T.; Enokida, H.; Seki, N. microRNA- 1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers. Oncotarget, 2012, 3, 9-21.
9. Fleming, J.L.; Gable, D.L.; Samadzadeh-Tarighat, S.; Cheng, L.; Yu, L.; Gillespie, J.L.; Toland, A.E. Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice. Peer J., 2013, 1, e68.
10. Hudson, R.S.; Yi, M.; Esposito, D.; Watkins, S.K.; Hurwitz, A.A.; Yfantis, H.G.; Lee, D.H.; Borin, J.F.; Naslund, M.J.; Alexander, R.B.; Dorsey, T.H.; Stephens, R.M.; Croce, C.M.; Ambs, S. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res., 2012, 40, 3689-703.
11. Nasser, M.W.; Datta, J.; Nuovo, G.; Kutay, H.; Motiwala, T.; Majumder, S.; Wang, B.; Suster, S.; Jacob, S.T.; Ghoshal, K. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem., 2008, 283, 33394-33405.
12. Bronisz, A.; Wang, Y.; Nowicki, M.O.; Peruzzi, P.; Ansari, K.I.; Ogawa, D.; Balaj, L.; De Rienzo, G.; Mineo, M.; Nakano, I.; Ostrowski, M.C.; Hochberg, F.; Weissleder, R.; Lawler, S.E.; Chiocca, E.A.; Godlewski, J. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res., 2014, 74, 738-750.
13. Mansouri, S.; Lavigne, P.; Corsi, K.; Benderdour, M.; Beaumont, E.; Fernandes, J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm., 2004, 57, 1-8.
14. Huang, X.; Schwind, S.; Yu, B.; Santhanam, R.; Wang, H.; Hoellerbauer, P.; Mims, A.; Klisovic, R.; Walker, A.R.; Chan, K.K.; Blum, W.; Perrotti, D.; Byrd, J.C.; Bloomfield, C.D.; Caligiuri, M.A.; Lee, R.J.; Garzon, R.; Muthusamy, N.; Lee, L.J.; Marcucci, G. Targeted delivery of microRNA-29b by transferrinconjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin. Cancer Res., 2013, 19, 2355-2367.
15. Miyazaki, T.; Pan, Y.; Joshi, K.; Purohit, D.; Hu, B.; Demir, H.; Mazumder, S.; Okabe, S.; Yamori, T.; Viapiano, M.; Shin-ya, K.; Seimiya, H.; Nakano, I. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric Gquadruplex and inhibition of the proto-oncogene, c-Myb. Clin. Cancer Res., 2012, 18, 1268-1280.
16. Gu, C.; Banasavadi-Siddegowda, Y.K.; Joshi, K,; Nakamura, Y.; Kurt, H.; Gupta, S.; Nakano, I. Tumor-specific activation of the CJUN/ MELK pathway regulates glioma stem cell growth in a p53- dependent manner. Stem Cells, 2013, 31, 870-881.
17. Jijiwa, M.; Demir, H.; Gupta, S.; Leung, C.; Joshi, K.; Orozco, N.; Huang ,T.; Yildiz, V.O.; Shibahara, I.; de Jesus, J.A.; Yong, W.H.; Mischel, P.S.; Fernandez ,S.; Kornblum, H.I.; Nakano, I. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One, 2011, 6, e24217.
18. Zhang, X.; Koh, C.G.; Yu, B.; Liu, S.; Piao, L.; Marcucci, G.; Lee, R.J.; Lee, L.J. Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model. Pharm. Res., 2009, 26, 1516-1524.
19. Zheng, Y.; Yu, B.; Weecharangsan, W.; Piao, L.; Darby, M.; Mao, Y.; Koynova, R.; Yang, X.; Li, H.; Xu, S.; Lee, L.J.; Sugimoto, Y.; Brueggemeier, R.W.; Lee, R.J. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int. J. Pharm., 2010, 390, 234-241.
20. Yang, X.; Koh, C.G.; Liu, S.; Pan, X.; Santhanam, R.; Yu, B.; Peng, Y.; Pang, J.; Golan, S.; Talmon, Y.; Jin, Y.; Muthusamy, N.; Byrd, J.C.; Chan, K.K.; Lee, L.J.; Marcucci, G.; Lee, R.J. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotideagainst Bcl-2. Mol. Pharm., 2009, 6, 221-230.
21. Yu, B.; Hsu, S.H.; Zhou, C.; Wang, X.; Terp, M.C.; Wu, Y.; Teng, L.; Mao, Y.; Wang, F.; Xue, W.; Jacob, S.T.; Ghoshal, K.; Lee, R.J.; Lee, L.J. Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials, 2012, 33, 5924-5934.
22. Hu, X.; Jin, L.; Feng, L. Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of postnatal neural stem cells. J. Neurochem., 2004, 90,1339-1347.
23. Wang, X.; Yu, B.; Wu, Y.; Lee, R.J.; Lee, L.J. Efficient downregulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery. Anticancer Res., 2011, 31, 1619-1626.
24. Kang, M.K.; Kang, S.K. Tumorigenesis of chemotherapeutic drugresistant cancer stem-like cells in brain glioma. Stem Cells Dev., 2007, 16, 837-847.
25. Oda, K.; Matsuoka, Y.; Funahashi, A.; Kitano, H.A. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol., 2005,0010.
26. Datta, J.; Kutay, H.; Nasser, M.W.; Nuovo, G.J.; Wang, B.; Majumder, S.; Liu, C.G.; Volinia, S.; Croce, C.M.; Schmittgen, T.D.; Ghoshal, K.; Jacob, S.T. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res., 2008, 68, 5049-5058.
27. Hernández-Pedro, N.Y.; Rangel-López, E.; Magaña-Maldonado, R.; de la Cruz, V.P.; del Angel, A.S.; Pineda, B.; Sotelo, J. Application of nanoparticles on diagnosis and therapy in gliomas. Biomed. Res. Int., 2013, 351031.
28. Kota, J.; Chivukula, R.R.; O'Donnell, K.A.; Wentzel, E.A.; Montgomery, C.L.; Hwang, H.W.; Chang, T.C.; Vivekanandan, P.; Torbenson, M.; Clark, K.R.; Mendell, J.R.; Mendell, J.T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 2009, 137, 1005-1017.
29. Christensen, M.; Larsen, L.A.; Kauppinen, S.; Schratt, G. Recombinant adeno-associated virus-mediated microRNA delivery into the postnatal mouse brain reveals a role for miR-134 in dendritogenesis in vivo. Front. Neural. Circuits, 2010, 3, 16.
30. Wiggins, J.F.; Ruffino, L.; Kelnar, K.; Omotola, M.; Patrawala, L.; Brown, D.; Bader, A.G. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res., 2010, 70, 5923-5930.
31. Zhang, Y.; Zhou, C.; Kwak, K.J.; Wang, X.; Yung, B.; Lee, L.J.; Wang, Y.; Wang, P.G.; Lee, R.J. Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core. Pharm. Res., 2012, 29, 1627-1636.
32. Yu, B.; Wang, X.; Zhou, C.; Teng, L.; Ren, W.; Yang, Z.; Shih, C.H.; Wang, T.; Lee, R.J.; Tang, S.; Lee, L.J. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm. Res., 2014.
33. Trang, P.; Wiggins, J.F.; Daige, C.L.; Cho, C.; Omotola, M.; Brown, D.; Weidhaas, J.B.; Bader, A.G.; Slack, F.J. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther., 2011, 19, 1116-1122.
34. Chen, Y.; Zhu, X.; Zhang, X.; Liu, B.; Huang, L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther., 2010, 18, 1650-1656.
35. Piao, L.; Zhang, M.; Datta, J.; Xie, X.; Su, T.; Li, H.; Teknos, T.N.; Pan, Q. Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. Mol. Ther., 2012, 20, 1261-1269.
36. Wu, Y.; Crawford, M.; Yu, B.; Mao, Y.; Nana-Sinkam, S.P.; Lee, L.J. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol. Pharm., 2011, 8, 1381-1389.
37. Liu, C.; Kelnar, K.; Liu, B.; Chen, X.; Calhoun-Davis, T.; Li, H.; Patrawala, L.; Yan, H.; Jeter, C.; Honorio, S.; Wiggins, J.F.; Bader, A.G.; Fagin, R.; Brown, D.; Tang, D.G. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med., 2011, 17, 211-215.
38. Craig, V.J.; Tzankov, A.; Flori, M.; Schmid, C.A.; Bader, A.G.; Muller, A. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia, 2012, 26, 2421-2424.
39. Yang, Z.; Yu, B.; Zhu, J.; Huang, X.; Xie, J.; Xu, S.; Yang, X.; Wang, X.; Yung, B.C.; Lee, L.J.; Lee, R.J.; Teng, L. A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia. Nanoscale, 2014, 6, 9742-9751.
40. Liu, Y.; Ji, M.; Wong, M.K.; Joo, K.I.; Wang, P. Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery. Biomed. Res. Int., 2013, 2013, 378380.
41. Gao, H.; Zhang, Q.; Yu, Z.; He, Q. Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery. Curr. Pharm. Biotechnol., 2014.
42. Yu, Z.; Schmaltz, R.M.; Bozeman, T.C.; Paul, R.; Rishel, M.J.; Tsosie, K.S.; Hecht, S.M. Selective tumor cell targeting by the disaccharide moiety of bleomycin. J. Am. Chem. Soc., 2013, 135, 2883-2886.
43. Bhattacharya, C.; Yu, Z.; Rishel, M.J.; Hecht, S.M. The carbamoylmannose moiety of bleomycin mediates selective tumor cell targeting. Biochemistry, 2014, 53, 3264-3266.